Paragon Capital

Paragon Biosciences is a life science innovator that creates, builds, and funds a portfolio of independent bioscience companies. Founded by Jeff Aronin, the firm focuses on severe medical conditions with significant unmet needs, utilizing a model that combines early-risk capital with strategic advisory and operational support. Its portfolio includes notable companies such as Harmony Biosciences, Castle Creek Biosciences, and Emalex Biosciences, spanning therapeutic areas like neurology, rare diseases, and gene therapy. Through its subsidiary, Paragon Health Capital, the firm also provides specialized financial and M&A services to its portfolio companies.